Literature DB >> 19567622

Biomarkers of chronic uveitis in juvenile idiopathic arthritis: predictive value of antihistone antibodies and antinuclear antibodies.

Ellen B Nordal1, Nils T Songstad, Lillemor Berntson, Torolf Moen, Bjørn Straume, Marite Rygg.   

Abstract

OBJECTIVE: To study the predictive value of antinuclear autoantibody (ANA) tests and antihistone antibodies (AHA) as risk factors for development of chronic asymptomatic uveitis of insidious onset in juvenile idiopathic arthritis (JIA).
METHODS: ANA by indirect immunofluorescence using HEp-2 cells (IF-ANA), ELISA for ANA (E-ANA), and AHA were analyzed in sera of 100 children with recent-onset JIA and in 58 control sera. Clinical features, including age at onset, JIA subgroup, and presence of uveitis, were recorded in this prospective population-based cohort study.
RESULTS: E-ANA was positive in 4 of the 100 sera, and was not associated with uveitis. Chronic uveitis developed in 16 children with JIA: in 14 of 68 positive for IF-ANA >/= 80, and in 13 of 44 positive for AHA >/= 8 U/ml. IgM/IgG AHA were found in higher proportions in children with uveitis (mean 12.4 U/ml) than in those with JIA and no uveitis (mean 6.9 U/ml) or in healthy controls (mean 4.3 U/ml).
CONCLUSION: No association was found between E-ANA and uveitis, and most IF-ANA-positive sera were E-ANA-negative. E-ANA is not clinically relevant in this setting and should never be used to determine frequencies of eye examinations to detect new uveitis in JIA. AHA >/= 8 U/ml, IF-ANA titer >/= 320, and young age at onset of arthritis were significant predictors for development of chronic uveitis. The diagnostic value of AHA >/= 8 U/ml as a biomarker of chronic uveitis in JIA is very similar to IF-ANA >/= 80.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19567622     DOI: 10.3899/jrheum.081318

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  21 in total

1.  Elevated IgG autoantibody production in oligoarticular juvenile idiopathic arthritis may predict a refractory course.

Authors:  M L Stoll; Q-Z Li; J Zhou; M Punaro; N J Olsen
Journal:  Clin Exp Rheumatol       Date:  2011-09-01       Impact factor: 4.473

2.  Remission rate is not dependent on the presence of antinuclear antibodies in juvenile idiopathic arthritis.

Authors:  M Glerup; T Herlin; M Twilt
Journal:  Clin Rheumatol       Date:  2017-01-17       Impact factor: 2.980

3.  Development of a vision-related quality of life instrument for children ages 8-18 years for use in juvenile idiopathic arthritis-associated uveitis.

Authors:  Sheila T Angeles-Han; Kenneth W Griffin; Melanie J Harrison; Thomas J A Lehman; Traci Leong; Rachel Reeves Robb; Marla Shainberg; Lori Ponder; Phoebe Lenhart; Amy Hutchinson; Sunil K Srivastava; Sampath Prahalad; Scott R Lambert; Carolyn Drews-Botsch
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-09       Impact factor: 4.794

Review 4.  Uveitis associated with juvenile idiopathic arthritis.

Authors:  Ethan S Sen; Andrew D Dick; Athimalaipet V Ramanan
Journal:  Nat Rev Rheumatol       Date:  2015-03-31       Impact factor: 20.543

5.  An Update on Treatment of Pediatric Chronic Non-Infectious Uveitis.

Authors:  Arjun B Sood; Sheila T Angeles-Han
Journal:  Curr Treatm Opt Rheumatol       Date:  2017-01-29

6.  Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests.

Authors:  Karl Egerer; Dirk Roggenbuck; Rico Hiemann; Max-Georg Weyer; Thomas Büttner; Boris Radau; Rosemarie Krause; Barbara Lehmann; Eugen Feist; Gerd-Rüdiger Burmester
Journal:  Arthritis Res Ther       Date:  2010-03-09       Impact factor: 5.156

Review 7.  Antibody-dependent and -independent mechanisms of inflammatory arthritis.

Authors:  Margaret H Chang; Peter A Nigrovic
Journal:  JCI Insight       Date:  2019-03-07

8.  Antinuclear antibody screening by ELISA and IF techniques: discrepant results in juvenile idiopathic arthritis but consistency in childhood systemic lupus erythematous.

Authors:  Mihaela Spârchez; Dan Delean; Gabriel Samaşcă; Nicolae Miu; Zeno Spârchez
Journal:  Clin Rheumatol       Date:  2014-02-21       Impact factor: 2.980

Review 9.  Treatment of uveitis associated with juvenile idiopathic arthritis.

Authors:  Rosa Bou; Estíbaliz Iglesias; Jordi Antón
Journal:  Curr Rheumatol Rep       Date:  2014-08       Impact factor: 4.592

10.  Risk markers of juvenile idiopathic arthritis-associated uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry.

Authors:  Sheila T Angeles-Han; Christina F Pelajo; Larry B Vogler; Kelly Rouster-Stevens; Christine Kennedy; Lori Ponder; Courtney McCracken; Jorge Lopez-Benitez; Carolyn Drews-Botsch; Sampath Prahalad
Journal:  J Rheumatol       Date:  2013-11-01       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.